retatrutide phase 2 study results Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, 2 trial conducted in the USA Phase 2 Trial of Retatrutide

A phase 3 trial comparing retatrutide with tirzepatide in adults with obesity is listed on ClinicalTrials.gov, which should provide more direct comparison data when completed and published 15

If youve reached a plateau in your weight loss journey with liraglutide, your doctor may suggest switching to semaglutide GLP-1 for potentially better results

Feedback across Trustpilot and Reddit threads reflects a generally positive experience, with most praise directed at pricing transparency and the quality of clinical support

2023 Jan;123(1):117143

Eli Lilly has applied for licensing in more than 40 countries for both type 2 diabetes and weight management, with plans for a rapid launch if its approved

The brain has its own GLP-1 signaling system, which helps guide appetite in ways researchers are still just beginning to unravel